Tuesday, March 19, 2024
wellness India Expo
Home Tags Dr Krishna Ella

Tag: Dr Krishna Ella

UW-Madison Global Health Institute partners Ella Foundation to establish first-ever ‘UW-Madison...

Partnership expands the Wisconsin Idea by providing interdisciplinary collaborations with UW-Madison, the Ella Foundation, and Bharat Biotech

Bharat Biotech launches iNNCOVACC, world’s first intranasal Covid-19 vaccine

The vaccine is priced at INR 325/dose for large volume procurement by state governments and union government

Sapigen Biologix to develop intranasal Covid-19 & malaria vaccines at estimated...

TDB-DST supported Sapigen helmed by Dr Krishna Murthy Ella to set up state -of- the -art world- class vaccine manufacturing facility in Bhubaneswar, Odisha

BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic

Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India

Biotech stalwarts to be honored with Padma Bhushan Award

Dr Cyrus Poonawalla of Serum Institute of India; and Dr Krishna Ella and Suchitra Ella of Bharat Biotech have found their place in the just released list of Padma Awards. They will be honored with Padma Bhushan for the role played by their companies during Covid-19 pandemic

CSIR-IMTECH celebrates its 38th Foundation Day

Dr. Krishna Ella, Chairman & Managing Director of Bharat Biotech International Limited delivered this year’s Foundation Day Lecture virtually on ‘Innovation and Leadership in Pandemic’

COVAXIN for children: Study demonstrates robust safety & immunogenicity in 2-18...

Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults......................

India’s one billion vaccinations feat: Stakeholders hail mammoth effort to achieve...

In a historic achievement, the cumulative COVID-19 vaccine doses administered in the country has surpassed the 100-crore milestone........................

Govt lauds Indian Immunologicals for producing COVID-19 drug substance in record...

Due to IIL’s prior experience in producing different types of viral vaccines for human and veterinary use, it could upgrade the existing facility and execute technology transfer, manufacturing, testing, and release of drug substances at lightning speed................

Bharat Biotech unveils first commercial batch of COVAXIN manufactured in Ankleshwar

The vaccine batches manufactured from Ankleshwar facilities in Gujarat will be available for supplies starting September 2021.........................